{
    "title": "China bars GSK from bulk-buy drug programme for 18 months",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11373221/China-bars-GSK-national-drug-bulk-buy-programme-drug-irregularities.html",
    "date": "2022-10-31",
    "keywords": [
        "gsk",
        "programme",
        "company",
        "grover",
        "drug",
        "procurement",
        "quality",
        "vbp",
        "year",
        "china",
        "beijinglondon",
        "drugmaker",
        "monday",
        "cctv",
        "state",
        "television",
        "ban",
        "batch",
        "treatment",
        "dutasteride",
        "brand",
        "name",
        "contract",
        "manufacturer",
        "spokesperson",
        "accounting",
        "country",
        "scheme",
        "uptake",
        "cost",
        "part",
        "bulk",
        "exclusion",
        "setback",
        "priority",
        "region",
        "growth",
        "ambition",
        "instance",
        "future",
        "standalone",
        "business",
        "spinoff",
        "consumer",
        "health",
        "volume",
        "demand",
        "shingrix",
        "newsroom",
        "brenda",
        "goh",
        "editing",
        "jason",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}